Treatment of Dravet Syndrome

Effect of CYP2C19 polymorphisms on stiripentol administration in Japanese cases of Dravet syndrome

(2015) Takeshi Kouga et al.   BRAIN & DEVELOPMENT

Parental reporting of response to oral cannabis extracts for treatment of refractory epilepsy

(2015) Craig A. Press et al.   EPILEPSY & BEHAVIOR

Efficacy and tolerability of the ketogenic diet in Dravet syndrome – Comparison with various standard antiepileptic drug regimen

(2015) Anastasia Dressler et al.   EPILEPSY RESEARCH

Long-term safety and efficacy of stiripentol for the treatment of Dravet syndrome: A multicenter, open-label study in Japan

(2015) Yushi Inoue et al.   EPILEPSY RESEARCH

Vagus nerve stimulation for drug-resistant epilepsy: A European long-term study up to 24 months in 347 children

(2014) Iren Orosz et al.   EPILEPSIA

Effectiveness of add-on stiripentol to clobazam and valproate in Japanese patients with Dravet syndrome: Additional supportive evidence

(2014) Yushi Inoue et al.   EPILEPSY RESEARCH

Sleep Abnormalities in Children With Dravet Syndrome

(2014) Radhika Dhamija et al.   PEDIATRIC NEUROLOGY

Stiripentol in refractory status epilepticus

(2013) Denise K. Grosenbaugh et al.   EPILEPSIA

Stiripentol in Dravet syndrome: Results of a retrospective U.S. study

(2013) Elaine C. Wirrell et al.   EPILEPSIA

The Ketogenic Diet in Dravet Syndrome

(2013) Linda Laux et al.   JOURNAL OF CHILD NEUROLOGY

Encephalopathy in children with Dravet syndrome is not a pure consequence of epilepsy

(2013) Rima Nabbout et al.   Orphanet Journal of Rare Diseases

Dravet syndrome: Seizure control and gait in adults with different SCN1A mutations

(2012) Jennifer J. Rilstone et al.   EPILEPSIA

Successful use of fenfluramine as an add-on treatment for Dravet syndrome

(2012) Berten Ceulemans et al.   EPILEPSIA

Effect of Vagus Nerve Stimulation in an Adult Patient with Dravet Syndrome: Contribution to Sudden Unexpected Death in Epilepsy Risk Reduction?

(2012) Marianna Spatola et al.   EUROPEAN NEUROLOGY

Bromide in Patients with SCN1A-Mutations Manifesting as Dravet Syndrome

(2012) Jan Lotte et al.   NEUROPEDIATRICS

Dravet syndrome - considerable delay in making the diagnosis

(2011) A. Bremer et al.   ACTA NEUROLOGICA SCANDINAVICA

Nonpharmacologic treatments of Dravet syndrome: Focus on the ketogenic diet

(2011) Roberto Horacio Caraballo   EPILEPSIA

The effects of stiripentol on GABAA receptors

(2011) Janet L. Fisher   EPILEPSIA

Dravet syndrome and parent associations: The IDEA League experience with comorbid conditions, mortality, management, adaptation, and grief

(2011) Joan V. Skluzacek et al.   EPILEPSIA

Ketogenic diet also benefits Dravet syndrome patients receiving stiripentol: A prospective pilot study

(2011) Rima Nabbout et al.   EPILEPSIA

Low long-term efficacy and tolerability of add-on rufinamide in patients with Dravet syndrome

(2011) A. Mueller et al.   EPILEPSY & BEHAVIOR

Clinical course of young patients with Dravet syndrome after vagal nerve stimulation

(2010) Nelia Zamponi et al.   EUROPEAN JOURNAL OF PAEDIATRIC NEUROLOGY

Unusual consequences of status epilepticus in Dravet syndrome

(2010) M. Chipaux et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Management of and prophylaxis against status epilepticus in children with severe myoclonic epilepsy in infancy (SMEI; Dravet syndrome) – A nationwide questionnaire survey in Japan

(2008) Takuya Tanabe et al.   BRAIN & DEVELOPMENT

Vagus nerve stimulation for refractory epilepsy in children: More to VNS than seizure frequency reduction

(2008) Amre Shahwan et al.   EPILEPSIA

The anti-convulsant stiripentol acts directly on the GABAA receptor as a positive allosteric modulator

(2008) Janet L. Fisher   NEUROPHARMACOLOGY

Vagus nerve stimulation in pediatric epileptic syndromes

(2008) E. Rossignol et al.   SEIZURE-EUROPEAN JOURNAL OF EPILEPSY

Severe myoclonic epilepsy in infancy: A systematic review and a meta-analysis of individual patient data

(2007) Behrouz Kassaï et al.   EPILEPSIA